ACTRN12615001337561已完成不适用
Prospective, single-masked, bilateral wear, crossover, clinical trial to assess visual performance of prototype contact lens designs for astigmatism compared to commercial contact lenses
Brien Holden Vision Pty Ltd0 个研究点目标入组 35 人开始时间: 2015年12月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 40 Years（—）
- 性别
- All
入选标准
- •* Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent.
- •* Be at least 18 years old, male or female.
- •* Have astigmatism between -0.75 D and -2.00D.
- •* Willing to comply with the wearing and clinical trial visit schedule as directed by the Investigator.
- •* Have ocular health findings considered to be normal” and which would not prevent the participant from safely wearing contact lenses.
- •* Correctable to at least 6/12 (20/40) or better in each eye with contact lenses.
- •* Be suitable and willing to wear contact lenses
排除标准
- •* Any pre-existing ocular irritation, injury or condition (including infection or disease) of the cornea, conjunctiva or eyelids that would preclude contact lens fitting and safe wearing of contact lenses.
- •* Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, and auto immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjögrens syndrome and systemic lupus erythematosus. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants.
- •* Use of or a need for concurrent category S3 and above ocular medication at enrolment. However, ocular medication can be prescribed during the course of the trial as per standard optometric practice.
- •* Use of or a need for any systemic medication or topical medications which may alter normal ocular findings / are known to affect a participant’s ocular health / physiology or contact lens performance either in an adverse or beneficial manner at enrolment and/or during the clinical trial.
- •NB: Systemic antihistamines are allowed on an as needed basis”, provided they are not used prophylactically during the trial and at least 24 hours before the clinical trial product is used.
- •* Eye surgery within 12 weeks immediately prior to enrolment for this trial.
- •* Previous corneal refractive surgery.
- •* Contraindications to contact lens wear.
- •* Known allergy or intolerance to ingredients in any of the clinical trial products.
- •* Currently enrolled in another clinical trial.
研究者
相似试验
撤回
不适用
A short-term evaluation of the accommodative responses of 6 contact lenses for myopia control and a control lens.Ocular AccommodationEye - Diseases / disorders of the eyeMyopiaACTRN12618001790235Brien Holden Vision Institute57
已完成
不适用
An evaluation of a new contact lens design against two prototype designs and a commercially-available single vision desigEye - Diseases / disorders of the eyeMyopiaACTRN12617000819325Brien Holden Vision Institute35
已完成
不适用
Dispensing study to assess the visual performance of optimised prototype contact lensesMyopiaPresbyopiaACTRN12617000247370Brien Holden Vision Pty Ltd120
已完成
不适用
Dispensing study to assess the visual performance of optimised prototype contact lensesEye - Normal eye development and functionPresbyopiaACTRN12615000652572Brien Holden Vision Pty Ltd150
已完成
不适用
Visual performance of prototype contact lens designs.Eye - Normal eye development and functionMyopiaPresbyopiaACTRN12614000776606Brien Holden Vision Pty Ltd60